prof. Isabelle Colle
- ORCID iD
- 0000-0001-9109-7570
Show
Sort by
-
- Journal Article
- A1
- open access
Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease : a multi‐centric prospective study
-
- Journal Article
- A1
- open access
Holmium-166 transarterial radioembolization for the treatment of intrahepatic cholangiocarcinoma : a case series
-
- Journal Article
- A1
- open access
Splanchnic vein thrombosis associated with SARS-CoV-2 infection : a VALDIG case–control study
-
- Journal Article
- A1
- open access
Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1 : a landmark analysis
-
Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension
-
Hereditary hemorrhagic telangiectasia and liver involvement : vascular liver diseases : position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver
-
Vasomodulators and liver transplantation for portopulmonary hypertension : evidence from a systematic review and meta-analysis
-
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury
-
Oral vasodilator treatment and liver transplantation for portopulmonary hypertension : systematic review and meta-analysis of hemodynamic response and prognosis
-
- Journal Article
- A1
- open access
Unfolded protein response is an early, non-critical event during hepatic stellate cell activation
-
Why pulse oximetry is inaccurate in liver cirrhosis : ancient knowledge
-
Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension : a randomized trial
-
Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease
-
Outcome of liver transplantation for hepatopulmonary syndrome : a Eurotransplant experience
-
IgG4-related disease of the hepatobiliary tract : 2 case reports and review of the literature
-
A new 'treatment-response score' for AUTO immune hepatitis is predictive of LONG-TERM event-free survival and overall survival : a multicenter Belgian cohort study
-
Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium
-
Hepatorenal syndrome : the clinical impact of vasoactive therapy
-
- Journal Article
- A1
- open access
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
-
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice
-
Anti-placental growth factor therapy attenuates experimental hepatopulmonary syndrome
-
- Journal Article
- A1
- open access
Modulation of the unfolded protein response by tauroursodeoxycholic acid counteracts apoptotic cell death and fibrosis in a mouse model for secondary biliary liver fibrosis
-
Hepatitis E virus serology and PCR : does the methodology matter?
-
Combination of tauroursodeoxycholic acid and N-acetylcysteine exceeds standard treatment for acetaminophen intoxication
-
Phenotype of hepatocellular neoplasms associated with androgen use
-
AISF position paper on liver transplantation and pregnancy : Women in Hepatology Group, Italian Association for the Study of the liver (AISF)
-
Kinetics of pulmonary angiogenesis in mouse common bile duct ligation-induced liver fibrosis
-
The bile acid tauroursodeoxycholic acid cooperates with N-acetylcysteine in the treatment of experimental acetaminophen-induced hepatotoxicity
-
Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice
-
Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis : a prospective study
-
The role of macrophages in obesity-driven chronic liver disease
-
Deadly air
-
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
-
Experimental models of liver fibrosis
-
Somatostatin (Eumedica®) infusion allows modulating graft flows and gradients in liver transplantation: results of a randomized, double blind, placebo controlled trial
-
Somatostatin infusion allows reversible graft flows and pressure gradient modulation in clinical liver transplantation: results of a randomized, double blind, placebo controlled trial
-
Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience
-
Varices, portal hypertensive gastropathy and GAVE
-
Hepatopulmonary syndrome and portopulmonary hypertension : recent knowledge in pathogenesis and overview of clinical assessment
-
Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome
-
Clinical burden of hepatitis E infections in Belgium
-
Living donor versus deceased donor liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF and Asan criteria: long-term follow-up
-
Late liver retransplantation with deceased and living donor liver grafts: a comparative single institution analysis
-
Prevalence and outcome of diastolic dysfunction in liver transplantation recipients
-
Cutaneous infection by Alternaria infectoria in a liver transplant recipient: a case report
-
Hepatitis mouse models : from acute-to-chronic autoimmune hepatitis
-
Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent
-
Endoplasmic reticulum stress and angiogenesis: is there an interaction between them?
-
Anale last : vreemde duikers
-
- Journal Article
- A1
- open access
Role of IRAK-M in alcohol induced liver injury
-
- Journal Article
- A1
- open access
Liver transplantation for alcoholic liver disease: a retrospective analysis of recidivism, survival and risk factors predisposing to alcohol relapse
-
The therapeutic potential of artesunate in hepatocellular carcinoma
-
Expansion of memory-type CD8⁺ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin
-
Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report
-
Temporal dynamics of the unfolded protein response and chemoresistance in hepatocellular carcinoma
-
Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years
-
Pathophysiology and management of post resection liver failure
-
Boceprevir-based triple therapy for Belgian liver transplant patients infected with hepatitis C virus: a preliminary experience
-
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values
-
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
-
Calciphylaxis: a rare complication in alcoholic liver disease
-
Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation
-
Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: a review
-
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model
-
Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor
-
Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis : a review
-
Comparison of mono-institutional survival of radiolabelled lipiodol versus yttrium-90 microspheres for hepatocellular carcinoma
-
Hepatocellular carcinoma (HCC) treatment with radiolabelled lipiodol embolization versus yttrium-90 radioembolization: comparative survival analysis
-
Hepatitis E seroprevalence in Belgium
-
Expansion of memory type CD8+t-cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high doses atg induction and rapamycin
-
Ascites: not always the usual suspects
-
Hepatitis E seroprevalence in East and West Flanders, Belgium
-
Resource use and cost of hepatitis C-related care
-
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model
-
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
-
Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice
-
Prospective randomized double blind placebo controled study on the effect of somatostatin eumedica (R) on graft inflow modulation and I/R injury in liver transplantation: preliminary results
-
The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth
-
N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis
-
Hepatitis E seroprevalence in Belgium
-
Targeting angiogenesis in chronic liver diseases with portal hypertension : anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib? : reply
-
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use ?
-
- Journal Article
- A1
- open access
FibroSURE™ and FibroScan® in relation to treatment response in chronic hepatitis C virus
-
Upper gastrointestinal tract bleeding management: Belgian guidelines for adults and children (vol 74, pg 45, 2011)
-
Upper gastrointestinal tract bleeding management: Belgian guidelines for adults and children
-
Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C
-
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
-
Moyamoya disease as a possible cause of neurological impairment following liver transplantation for Wilson's disease
-
Expression of placental growth factor in regenerating livers after partial hepatectomy in the rat
-
Angiogenesis in chronic liver disease and its complications
-
The Fibro7-score: a novel serum proteome- and clinical biochemistry-based predictive model for chronic hepatitis C liver fibrosis
-
Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up
-
Invasive infection with Rhodococcus equi : two case reports and review of literature
-
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial
-
Early arterial revascularization after hepatic artery thrombosis may avoid graft loss and improve outcomes in adult liver transplantation
-
- Conference Paper
- C3
- open access
Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology
-
N-Glycosylation patterns of serum proteins to make the distinction between steatosis of the liver and non-alcoholic steatohepatitis in obese patients scheduled for bariatric surgery
-
- Conference Paper
- C3
- open access
Angiogenic changes in a new mouse model for hepatocellular carcinoma
-
Presence of liver angiogenesis and upregulation of VEGF in a mouse mice of non-alkoholic steatohepatitis (NASH)
-
Haemostasis monitoring during sequential aortic valve replacement and liver transplantation
-
Hypomagnesemia and the risk of new-onset diabetes after liver transplantation
-
LTx for alcoholic liver disease: a retrospective analysis of recidivism, survival and risk factors predisposing to alcohol relapse
-
Graft loss is significantly decreased and long-term survival advantages are improved after urgent early (<= 15 days) arterial revascularization in adult liver transplantation
-
Hypomagnesemia and the risk of new onset diabetes after liver transplantation
-
Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology
-
Inhibition of PlGF as a potential therapy against hepatocellular carcinoma
-
- Conference Paper
- C3
- open access
Effect of PlGF-inhibition on survival in mice with hepatocellular carcinoma
-
Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology
-
- Conference Paper
- C3
- open access
Angiogenic changes in a new mouse model for hepatocellular carcinoma
-
- Journal Article
- A1
- open access
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma
-
Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents
-
- Journal Article
- A1
- open access
Galectin-3-binding protein : a serological and histological assessment in accordance with hepatitis C-related liver fibrosis
-
- Journal Article
- A1
- open access
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study
-
Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B
-
Hepatic stellate cell activation: an important contributor to persistent hepatic resistance in small-for-size livers after extended partial hepatectomy in the rat
-
Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application (vol 41, pg 3485, 2009)
-
Blockage of PLGF improves inflammation, fibrosis, and portal pressure in cirrhotic mice
-
The impact of elevation of total bilirubin level on serum N-glycosylation patterns in mice and men
-
Liver transplantation for alcoholic liver disease: a retrospective analysis of recidivism, survival and risk factors predicting to alcohol relapse
-
Presence of liver angiogenesis and upregulation of the vascular endothelial growth factor (VEGF) in a mice model of non-alcoholic steatohepatitis (NASH)
-
The impact of elevation of total bilirubin level on serum N-glycosylation patterns in mice and men
-
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease
-
- Journal Article
- A1
- open access
The impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and men
-
Acute zwangerschapssteatose : een zeldzame verwikkeling tijdens de zwangerschap : twee patiëntencasussen en literatuuroverzicht
-
Biased expansion of memory-type CD8(+) T cells as a cause of acute rejection upon immunosuppression withdrawal in a tolerance pilot trial in liver transplantion
-
Analysis of wall shear stress in different models of portal hypertension and cirrhosis
-
Longitudinal dynamic studies of porto-systemic shunting in portal hypertensive and cirrhotic mice by quantitative micro-SPECT imaging
-
Analysis of wall shear stress in different models of portal hypertension and cirrhosis
-
Development of the hepatopulmonary syndrome in mice is accompanied with pulmonary angiogenesis
-
Deficiency in Placental Growth Factor improves inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic mice
-
Analysis of wall shear stress in different models of portal hypertension and cirrhosis
-
Homeostatic proliferation of memory-type CD8(+) T cells as a cause of acute rejection upon immunosuppression withdrawal in liver transplant recipients
-
ADULT SPLIT LIVER TRANSPLANTATION WITH eRLG FROM EXTENDED CRITERIA DONORS UNDER MELD PATIENT ALLOCATION
-
MELD ALLOCATION SYSTEM IN BELGIUM-ET AND OUTCOME
-
Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The 'ReSpECT' Study
-
Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?
-
Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?
-
Experimental mouse models for hepatocellular carcinoma research
-
Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension
-
Longitudinal dynamic studies of porto-systemic shunting in portal hypertensive and cirrhotic mice by quantitative micro-SPECT imaging
-
- Conference Paper
- C3
- open access
Efficient tissue incorporation of composite meshes used for incisional hernia repair after liver transplantation
-
Previous Intravenous Substance Use and Outcome of Liver Transplantation in Patients With Chronic Hepatitis C Infection
-
Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-gamma-secreting CD8(+) T Cells
-
Angiogenesis in liver disease
-
The HCV serum proteome: a search for fibrosis protein markers
-
Induction of Tolerance in Solid Organ Transplantation: The Rationale to Develop Clinical Protocols in Liver Transplantation
-
Intravital fluorescence microscopy study of the intrahepatic microcirculation during liver regeneration in different partial hepatectomy rat models
-
Steatosis induces significant, non-fibrosis related portal hypertension in association with signs of a hyperdynamic circulation and indicators of splanchnic vasodilation in vitro and in vivo in a rat model
-
Proteomic analysis to identify the pathophysiological role of placental growth factor (Plgf) in hepatic stellate cell function and cirrhosis
-
Influence of non-selective and selective endothelin - 1 receptor antagonists on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy
-
The use of antibodies against the placental growth factor in the prophylactic and therapeutic setting in portal hypertensive mice
-
The use of antibodies against the placental growth factor as a new therapeutic target in the pathophysiology of portal hypertensive mice
-
Influence of non-selective and selective endothelin-1 receptor antagonists on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital microscopy
-
Different glycosylation patterns in mice models of portal hypertension and cirrhosis
-
The use of antibodies against the placental growth factor in the prophylactic setting in the pathophysiology of portal hypertensive mice
-
Development of cirrhosis is associated with increased levels of placental growth factor: a descriptive study
-
Influence of bosentan on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital microscopy
-
Development of cirrhosis is associated with increased levels of placental growth factor
-
Deficiency in placental growth factor causes a decreased portosystemic collateral vessel information in portal hypertensive mice
-
Een patiënt met acute abdominale pijn en krachtverlies
-
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy (vol 28, pg 107, 2008)
-
HEPATITIS C-SEROCONVERSION WITHIN THREE TO SIX MONTHS AFTER HAVING CONTRACTED CLINICAL SYPHILIS AND/OR LYMPHOGRANULOMA VENEREUM RECTITIS IN FIVE HOMOSEXUALLY ACTIVE, HIV SEROPOSITIVE MEN
-
An economic evaluation of vasoactive agents used to treat acute bleeding oesophageal varices in Belgium
-
Weekly Pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection
-
The HCV Serum proteome: A search for fibrosis protein markers
-
EARLY IMMUNOSUPPRESSION WITHDRAWAL AFTER CADAVER LIVER TRANSPLANTATION USING ATG AND RAPAMYCIN IN THE IMMEDIATE POSTTRANSPLANT PERIOD
-
Auto-immune pancreatitis: 'another great imitator'. Drie patiënten met een pancreasmassa
-
Different N-glycosylation patterns in mice models of portal hypertension and cirrhosis
(2008) -
An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis
-
Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice
-
Deficiency in placental growth factor causes a decreased porto-systemic collateral vessel formation in portal hypertensive mice
-
Influence of bosentan on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital microscopy
-
Deficiency in placental growth factor causes a decreased porto-systemic collateral vessel formation in portal hypertensive mice
-
Proteomics in liver fibrosis is more than meets the eye
-
Hemodynamic changes in splanchnic blood vessels in portal hypertension
(2008) ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY. 291(6). p.699-713 -
'Hepatic' encephalopathy because of spontaneous mesenterico-caval shunt
-
Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation
-
Split liver transplantation with extended right grafts under patient-oriented allocation policy: single center matched-pair outcome analysis
-
Capsule endoscopy findings in cirrhosis with portal hypertension: A prospective study
-
Development of cirrhosis is associated with increased levels of placental growth factor: a descriptive study
-
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy
-
The value of laparoscopic liver surgery for solid benign hepatic tumors
-
Development of cirrhosis is associated with increased angiogenesis in the liver: study of the expression of vascular endothelial growth factors
-
The time-dependent release of angiogenetic factors in the splanchnic microvasculature in portal hypertension
-
Development of cirrhosis is associated with increased angiogenesis in the liver
-
Intravital microscopy study of the development of cirrhosis in CBDL and CCl4 mice models
-
Een praktisch overzicht van de aanpak van hepatitis C
-
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines
-
Development of cirrhosis is associated with increased angiogenesis in the liver
-
One-sided limb lymphedema in a liver transplant recipient receiving Sirolimus
-
Prediction of survival after late liver retransplantation with deceased and living donor liver grafts: A comparative analysis on preoperative prognostic scores.
-
Angiogenesis in portal hypertension: Involvement in increased splanchnic blood flow and collaterals?
-
Persistent posttransplant hyperbilirubinemia ((> 10 days/> 10 mg/dI) correlates with low graft and patient survival following A2ALDLT. A multivariate analysis of 143 consecutive A2ALDLT from the GhentParis beaujon series
-
Persistent posttransplant hyperbilirubinemia (> 10 days/> 10 mg/dl) correlates with low graft and patient survival following A2ALDLT. A multivariate analysis of 143 consecutive A2ALDLT from the Ghent-Paris Beaujon series
-
A rapid test of alloreactivity based on IL2 mRNA expression might identify liver transplant recipients developing donor-specific hyporesponsiveness
-
Adult living donor liver transplantation and innovative protocols. A single institutional experience
-
Evidence of prolonged overall survival using rapamycin as main immunosuppression in patients transplanted for primary hepatocellular carcinoma with extended criteria on pathology
-
Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon: an in vivo study
-
Hepatopulmonary syndrome and portopulmonary hypertension : what's new?
-
The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal?
-
A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsiveness
-
Indications, innovative protocols and long-term results in living donor liver transplantation in adults: a single-center experience
-
Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal hypertensive mice
-
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy
-
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital microscopy
-
Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal hypertensive mice
-
Development of portal hypertension and cirrhosis after CCL4 and CBDL in mice models : a histological and ultrastructural approach
-
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion
-
Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study
-
Specific problems in a HIV positive patient with end-stage alcoholic liver disease after liver transplantation: infections and immunosuppression
-
Re-188-HDD/lipiodol for treatment of hepatocellular carcinoma: A feasibility study in patients with advanced cirrhosis
-
In vivo vascular hyporeactivity in the mesenteric artery of rats with cirrhosis: reversed by chronic octreotide LAR administration
-
Induction of tolerance to living donor liver transplantation using myeloconditioning and donor stem cells infusion: A pilot study
-
The management of patients with mild hepatitis C
-
Impact of MELD on short-term and long-term outcome following liver transplantation : a European perspective
-
The HepCar registry : report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium: what is daily practice in HCC?
-
Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation
-
Guidelines for the management of chronic hepatitis C in patients infected after substance use
-
Hepatitis C infection-related liver disease: Patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults
-
Value of multidetector computed tomographic cholangiography (MDCT-CA) in the preoperative assessment of biliary anatomy in living donor liver surgery: A radiological-surgical comparison
-
Prolonged postoperative hyperbilirubinemia following adult-to-adult living donor liver transplantation - A multivariate analysis of associated risk factors influencing ouctome
-
Prolonged postoperative hyperbilirubinemia following adult-to-adult living donor liver transplantation - A multivariate analysis of associated risk factors
-
Higher MELD scores pre liver transplantation have no influence on the long term survival of the liver transplant patient
-
Decreased leukocyte recruitment in the peritoneal microcirculation of rats with portal hypertension: role of L-selectin?
-
Increased angiogenesis and permeabiliy in the peritoneal microcirculation of rats with portal hypertension and cirrhosis
-
Discussion on medical treatment of portal hypertension
-
Biliary complications in adult-to-adult living donor liver transplantations: Really a matter of learning curve?
-
Transplanted liver: Consequences of denervation for liver functions
(2004) ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY. 280A(1). p.924-931 -
Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft
-
Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study
-
Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients
-
Circulatory anomalies in cirrhosis and portal hypertension
(2003) -
Adult living donor liver transplantation in UNOS 2A and 2B patients with small-for-size grafts and graft inflow modulation using a permanent hemiportocaval shunt.
-
Modulation of portal graft inflow: A necessity in adult living-donor liver transplantation?. Vol. 237
-
Influence of posture on haemodynamics, sodium and hormonal homeostasis in cirrhotic patients with and without ascites
-
Sildenafil in rats with cirrhosis and portal hypertension: systemic and splanchnic haemodynamic effects
-
Een enterovaginale fistel secundair aan een geperforeerd Meckel's diverticulitis
-
Percutane endoscopische gastrostomie (PEG)
-
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial
-
Modulation of portal graft inflow: A necessity in adult living-donor liver transplantation?
-
Diagnosis and therapeutic problems of primary sclerosing cholangitis
-
Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study
-
Cholestasis as presenting symptom of portal cavernoma
-
Combining iodine-131 lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma
-
Liver transplantation and mental retardation
-
Risk factors for hepatitis C: past, present and future
-
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: A retrospective analysis
-
Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults?
-
Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients
-
Evolution of hypoxemia in patients with severe cirrhosis